Literature DB >> 18037614

Antithrombin III in critically ill patients.

A Torossian, J Graf, A Bauhofer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18037614      PMCID： PMC2137046          DOI： 10.1136/bmj.39399.552245.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Uncertainty in heterogeneity estimates in meta-analyses.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Evangelos Evangelou
Journal:  BMJ       Date:  2007-11-03

2.  HEPARIN AND BLOOD CLOTTING.

Authors:  K M Brinkhous; H P Smith; E D Warner; W H Seegers
Journal:  Science       Date:  1939-12-08       Impact factor: 47.728

3.  Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.

Authors:  Judith M Leitner; Christa Firbas; Florian B Mayr; Rosemarie A Reiter; Barbara Steinlechner; Bernd Jilma
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

4.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

5.  Changes in the blood coagulation system associated with septicemia.

Authors:  J J Corrigan; W L Ray; N May
Journal:  N Engl J Med       Date:  1968-10-17       Impact factor: 91.245

6.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

7.  Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

Authors:  J Kienast; M Juers; C J Wiedermann; J N Hoffmann; H Ostermann; R Strauss; H-O Keinecke; B L Warren; S M Opal
Journal:  J Thromb Haemost       Date:  2006-01       Impact factor: 5.824

Review 8.  Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis.

Authors:  Arash Afshari; Jørn Wetterslev; Jesper Brok; Ann Møller
Journal:  BMJ       Date:  2007-11-23

9.  Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.

Authors:  Mayuki Aibiki; Noriyasu Fukuoka; Takashi Nishiyama; Soichi Maekawa; Yoichi Shirakawa
Journal:  Shock       Date:  2007-08       Impact factor: 3.454

Review 10.  Evidence-based medicine: classifying the evidence from clinical trials--the need to consider other dimensions.

Authors:  Rinaldo Bellomo; Sean M Bagshaw
Journal:  Crit Care       Date:  2006       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.